Dose Ranging Study for Indacaterol in Japanese Asthma Patients

NCT00403754 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Indacaterol
DRUG: Placebo
DRUG: Salmeterol

Sponsor

Novartis Pharmaceuticals